title: Quantifying the decisional satisfaction to accept or reject the Human Papillomavirus (HPV) vaccine: a preference for cervical cancer prevention.
abstract: OBJECTIVE
  Only a portion of the US population is willing to consider HPV vaccination to date. The primary aim of this study is to determine the decisional satisfaction associated with HPV vaccination.
  
  
  METHODS
  This is a prospective survey conducted at an urban college where women 18-26 years old completed a decisional satisfaction survey about their HPV vaccine experience.
  
  
  RESULTS
  Regardless of the decision to accept or reject HPV vaccination, the decisional satisfaction was very high (mean 5-item score = 21.2 (SD 3.8)). Women without HPV vaccination were decisionally neutral significantly more often than those already vaccinated; 22% were decisionally neutral for the option to accept HPV vaccination at that visit. Cervical cancer prevention was preferred significantly more often than genital wart prevention in all analyses.
  
  
  CONCLUSIONS
  Targeting those who are decisionally neutral about HPV vaccination may result in a higher uptake of HPV vaccination.
authors.affiliation: Department of Community and Family Medicine, University of Missouri Kansas City School of Medicine, Kansas City, Missouri, United States of America ; Department of Obstetrics and Gynecology, University of Missouri Kansas City School of Medicine, Kansas City, Missouri, United States of America ; Department of Biomedical and Health Informatics University of Missouri Kansas City School of Medicine, Kansas City, Missouri, United States of America ; Student Health and Wellness, University of Missouri-Kansas City, Kansas City, Missouri, United States of America.
authors.forename: Diane M
authors.initials: DM
authors.lastname: Harper
authors.affiliation: Department of Community and Family Medicine, University of Missouri Kansas City School of Medicine, Kansas City, Missouri, United States of America ; Student Health and Wellness, University of Missouri-Kansas City, Kansas City, Missouri, United States of America.
authors.forename: Billy B
authors.initials: BB
authors.lastname: Irons
authors.affiliation: Department of Community and Family Medicine, University of Missouri Kansas City School of Medicine, Kansas City, Missouri, United States of America ; Department of Family Medicine, Kansas City University of Medicine and Biosciences, Kansas City, Missouri, United States of America.
authors.forename: Natalie M
authors.initials: NM
authors.lastname: Alexander
authors.affiliation: Student Health and Wellness, University of Missouri-Kansas City, Kansas City, Missouri, United States of America.
authors.forename: Johanna C
authors.initials: JC
authors.lastname: Comes
authors.affiliation: Student Health and Wellness, University of Missouri-Kansas City, Kansas City, Missouri, United States of America.
authors.forename: Melissa S
authors.initials: MS
authors.lastname: Smith
authors.affiliation: Student Health and Wellness, University of Missouri-Kansas City, Kansas City, Missouri, United States of America.
authors.forename: Melinda A
authors.initials: MA
authors.lastname: Heutinck
authors.affiliation: Student Health and Wellness, University of Missouri-Kansas City, Kansas City, Missouri, United States of America.
authors.forename: Sandra M
authors.initials: SM
authors.lastname: Handley
authors.affiliation: Department of Community and Family Medicine, University of Missouri Kansas City School of Medicine, Kansas City, Missouri, United States of America ; Student Health and Wellness, University of Missouri-Kansas City, Kansas City, Missouri, United States of America.
authors.forename: Debra A
authors.initials: DA
authors.lastname: Ahern
mesh_terms: D000293:Adolescent; D000328:Adult; D003657:Decision Making; D003710:Demography; D005260:Female; D006801:Humans; D030361:Papillomavirus Infections / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D053918:Papillomavirus Vaccines / Q000276:immunology*; D010342:Patient Acceptance of Health Care; D010549:Personal Satisfaction; D002583:Uterine Cervical Neoplasms / Q000276:immunology / Q000517:prevention & control* / Q000821:virology*; D014611:Vaccination / Q000706:statistics & numerical data; D055815:Young Adult
chemical_list: D053918:Papillomavirus Vaccines